Trials / Conditions / Subcutaneous Panniculitis-Like T-Cell Lymphoma

Subcutaneous Panniculitis-Like T-Cell Lymphoma

8 registered clinical trials studyying Subcutaneous Panniculitis-Like T-Cell Lymphoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Registry for People With T-cell Lymphoma NCT05978141	Memorial Sloan Kettering Cancer Center	—
Recruiting	A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas NCT05475925	Dren Bio	Phase 1 / Phase 2
Active Not Recruiting	Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas NCT03598998	City of Hope Medical Center	Phase 1 / Phase 2
Completed	Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma NCT02652715	Mayo Clinic	N/A
Unknown	CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL NCT02533700	Shandong Provincial Hospital	Phase 2
Active Not Recruiting	Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency NCT01787409	Mayo Clinic	N/A
Unknown	CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymph NCT01746992	Ruijin Hospital	Phase 4
Completed	Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas NCT01445535	National Cancer Institute (NCI)	Phase 1